These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16631419)

  • 41. Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity.
    Velagapudi UK; Langelier MF; Delgado-Martin C; Diolaiti ME; Bakker S; Ashworth A; Patel BA; Shao X; Pascal JM; Talele TT
    J Med Chem; 2019 Jun; 62(11):5330-5357. PubMed ID: 31042381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.
    Frigon L; Pascal JM
    Nucleic Acids Res; 2023 Dec; 51(22):12492-12507. PubMed ID: 37971310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).
    Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT
    J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
    Park CH; Chun K; Joe BY; Park JS; Kim YC; Choi JS; Ryu DK; Koh SH; Cho GW; Kim SH; Kim MH
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2250-3. PubMed ID: 20189385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity.
    Wang Z; Qian H; Yiu SM; Sun J; Zhu G
    J Inorg Biochem; 2014 Feb; 131():47-55. PubMed ID: 24239912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A shuttle mechanism for DNA-protein interactions. The regulation of poly(ADP-ribose) polymerase.
    Zahradka P; Ebisuzaki K
    Eur J Biochem; 1982 Oct; 127(3):579-85. PubMed ID: 6293817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
    Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple receptor conformation docking, dock pose clustering and 3D QSAR studies on human poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
    Fatima S; Jatavath MB; Bathini R; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2014 Oct; 34(5):417-30. PubMed ID: 25046176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs.
    Gagné JP; Ethier C; Defoy D; Bourassa S; Langelier MF; Riccio AA; Pascal JM; Moon KM; Foster LJ; Ning Z; Figeys D; Droit A; Poirier GG
    DNA Repair (Amst); 2015 Jun; 30():68-79. PubMed ID: 25800440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
    Chadha N; Jaggi AS; Silakari O
    Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.
    Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y
    Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The key residues of active sites on the catalytic fragment for paclitaxel interacting with poly (ADP-ribose) polymerase.
    Wang Y; Bian F; Deng S; Shi Q; Ge M; Wang S; Zhang X; Xu S
    J Biomol Struct Dyn; 2011 Jun; 28(6):881-93. PubMed ID: 21469749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement.
    Wigle TJ; Blackwell DJ; Schenkel LB; Ren Y; Church WD; Desai HJ; Swinger KK; Santospago AG; Majer CR; Lu AZ; Niepel M; Perl NR; Vasbinder MM; Keilhack H; Kuntz KW
    Cell Chem Biol; 2020 Jul; 27(7):877-887.e14. PubMed ID: 32679093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of novel PARP-1 inhibitors: Drug design, synthesis and biological evaluation.
    Xie Z; Zhou Y; Zhao W; Jiao H; Chen Y; Yang Y; Li Z
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4557-61. PubMed ID: 26342868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical characterization of mono(ADP-ribosyl)ated poly(ADP-ribose) polymerase.
    Mendoza-Alvarez H; Alvarez-Gonzalez R
    Biochemistry; 1999 Mar; 38(13):3948-53. PubMed ID: 10194306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach.
    Sharma MC
    Interdiscip Sci; 2016 Mar; 8(1):11-22. PubMed ID: 26205198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poly(ADP-ribose)-polymerase-catalyzed hydrolysis of NAD+: QM/MM simulation of the enzyme reaction.
    Bellocchi D; Costantino G; Pellicciari R; Re N; Marrone A; Coletti C
    ChemMedChem; 2006 May; 1(5):533-9. PubMed ID: 16892389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.